A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Gene ID | PubMed | Modification | Allele | Phenotype | Further Information | ||||||||||||||||||||
2 | CNAG_00025 | 20889719 | N/A | N/A | capsule formation: normal | capsule formation: normal | ||||||||||||||||||||
3 | CNAG_00025 | 20889719 | N/A | N/A | growth at host temperature: decreased | at 35 deg in the presence of cyclosporin A | ||||||||||||||||||||
4 | CNAG_00025 | 20889719 | N/A | N/A | resistance to calcium : decreased | at 30 deg in the presence of cyclosporin A | ||||||||||||||||||||
5 | CNAG_00025 | 23895559 | N/A | N/A | resistance to calcium : decreased | calcium(2+) (400 mM) | ||||||||||||||||||||
6 | CNAG_00025 | 20889719 | N/A | N/A | resistance to phagocytosis: increased | resistance to phagocytosis: increased | ||||||||||||||||||||
7 | CNAG_00025 | 20889719 | N/A | N/A | virulence: decreased | mouse pulmonary infection | ||||||||||||||||||||
8 | CNAG_00036 | 21453402 | N/A | sec14-2::NAT | viable | viable | ||||||||||||||||||||
9 | CNAG_00040 | 22155829 | reduction of function | erg11-Y145F | resistance to fluconazole: increased | fluconazole (MIC 128 ug/ml) | ||||||||||||||||||||
10 | CNAG_00040 | 22155829 | reduction of function | erg11-Y145F | resistance to itraconazole: decreased | itraconazole (MIC 0.38 ug/ml) | ||||||||||||||||||||
11 | CNAG_00040 | 22155829 | reduction of function | erg11-Y145F | resistance to posaconazole: decreased | resistance to posaconazole: decreased | ||||||||||||||||||||
12 | CNAG_00040 | 22155829 | reduction of function | erg11-Y145F | resistance to voriconazole: increased | resistance to voriconazole: increased | ||||||||||||||||||||
13 | CNAG_00051 | 18854164 | N/A | N/A | capsule formation: normal | 10% Sabouraud medium buffered to pH 7.3 with 50 mM MOPS, grown at 30 deg C for two days then stained with India ink | ||||||||||||||||||||
14 | CNAG_00051 | 18854164 | N/A | N/A | competitive fitness: decreased | decreased survival in mouse lungs assayed in pools of 48 STM mutants | ||||||||||||||||||||
15 | CNAG_00097 | 20689743 | N/A | N/A | virulence: normal | mouse pulmonary infection | ||||||||||||||||||||
16 | CNAG_00106 | 16672377 | N/A | N/A | viable | viable | ||||||||||||||||||||
17 | CNAG_00125 | 12933823 | N/A | N/A | mating response: increased | mating response: increased | ||||||||||||||||||||
18 | CNAG_00125 | 15302835 | N/A | N/A | mating response: increased | increased formation of conjugation tubes upon pheromone treatment | ||||||||||||||||||||
19 | CNAG_00125 | 15302835 | N/A | N/A | virulence: increased | mouse pulmonary infection | ||||||||||||||||||||
20 | CNAG_00130 | 18854164 | N/A | N/A | capsule formation: normal | 10% Sabouraud medium buffered to pH 7.3 with 50 mM MOPS, grown at 30 deg C for two days then stained with India ink | ||||||||||||||||||||
21 | CNAG_00130 | 21533251 | N/A | N/A | capsule formation: normal | capsule formation: normal | ||||||||||||||||||||
22 | CNAG_00130 | 18854164 | N/A | N/A | competitive fitness: increased | increased survival in mouse lungs assayed in pools of 48 STM mutants | ||||||||||||||||||||
23 | CNAG_00130 | 21533251 | N/A | N/A | melanin production: normal | melanin production: normal | ||||||||||||||||||||
24 | CNAG_00130 | 21533251 | N/A | N/A | resistance to fludioxonil: increased | fludioxonil (10, 30, 40 ug/ml) | ||||||||||||||||||||
25 | CNAG_00130 | 21533251 | N/A | N/A | virulence: normal | mouse pulmonary infection | ||||||||||||||||||||
26 | CNAG_00150 | 18854164 | N/A | N/A | virulence: normal | mouse pulmonary infection | ||||||||||||||||||||
27 | CNAG_00156 | 21487010 | N/A | N/A | capsule formation: increased | capsule formation: increased | ||||||||||||||||||||
28 | CNAG_00156 | 23251520 | N/A | crz1::NEO | capsule formation: normal | 72 h incubation at 37 deg C in RPMI medium with 5% CO2 | examined by differential interference microscopy after and staining with India ink | ||||||||||||||||||||
29 | CNAG_00156 | 23251520 | N/A | crz1::NEO | hyperosmotic stress resistance: normal | YPD with 1 M NaCl, 30 deg C | ||||||||||||||||||||
30 | CNAG_00156 | 21487010 | N/A | N/A | laccase activity: decreased | laccase activity: decreased | ||||||||||||||||||||
31 | CNAG_00156 | 23251520 | N/A | crz1::NEO | mating projection morphology: normal | V8 mating agar | ||||||||||||||||||||
32 | CNAG_00156 | 23251520 | N/A | crz1::NEO | melanin production: normal | L-DOPA plates containing 0.1% glucose | ||||||||||||||||||||
33 | CNAG_00156 | 23251520 | N/A | crz1::NEO | resistance to calcium chloride: normal | YPD with 400 mM CaCl2, 30 deg C | ||||||||||||||||||||
34 | CNAG_00156 | 21487010 | N/A | N/A | resistance to Calcofluor White: decreased | Calcofluor White (0.5 mg/ml) | ||||||||||||||||||||
35 | CNAG_00156 | 23251520 | N/A | crz1::NEO | resistance to Calcofluor White: decreased | 0.5 mg/ml | ||||||||||||||||||||
36 | CNAG_00156 | 21487010 | N/A | N/A | resistance to Congo Red: decreased | Congo Red (0.5%) | ||||||||||||||||||||
37 | CNAG_00156 | 23251520 | N/A | crz1::NEO | resistance to Congo Red: decreased | Congo Red (0.1%) | ||||||||||||||||||||
38 | CNAG_00156 | 21487010 | N/A | N/A | virulence: decreased | mouse intravenous infection | ||||||||||||||||||||
39 | CNAG_00162 | 14500501 | N/A | N/A | resistance to killing by host cells: decreased | gamma interferon- and LPS-stimulated macrophages | ||||||||||||||||||||
40 | CNAG_00162 | 14500501 | N/A | N/A | virulence: decreased | mouse pulmonary infection | ||||||||||||||||||||
41 | CNAG_00162 | 14500501 | N/A | N/A | virulence: normal | other model (inocculation into cisternae magnae of immunosuppressed rabbits) | ||||||||||||||||||||
42 | CNAG_00181 | 18854164 | N/A | N/A | competitive fitness: decreased | decreased survival in mouse lungs assayed in pools of 48 STM mutants | ||||||||||||||||||||
43 | CNAG_00193 | 21441208 | N/A | N/A | capsule formation: decreased | capsule formation: decreased | ||||||||||||||||||||
44 | CNAG_00193 | 20673806 | N/A | N/A | capsule formation: normal | capsule formation: normal | ||||||||||||||||||||
45 | CNAG_00193 | 20673806 | N/A | N/A | capsule production: normal | capsule production: normal | ||||||||||||||||||||
46 | CNAG_00193 | 20673806 | N/A | N/A | growth at host temperature: normal | growth at host temperature: normal | ||||||||||||||||||||
47 | CNAG_00193 | 21441208 | N/A | N/A | heat sensitivity: decreased | 40 deg | ||||||||||||||||||||
48 | CNAG_00193 | 21441208 | N/A | N/A | mating response: increased | enhanced filamentation and production of basidia in both unilateral and bilateral crosses | ||||||||||||||||||||
49 | CNAG_00193 | 21441208 | N/A | N/A | melanin production: increased | melanin production: increased | ||||||||||||||||||||
50 | CNAG_00193 | 20673806 | N/A | N/A | melanin production: normal | melanin production: normal | ||||||||||||||||||||
51 | CNAG_00193 | 20673806 | N/A | N/A | resistance to killing by host cells: normal | resistance to killing by host cells: normal | ||||||||||||||||||||
52 | CNAG_00193 | 20673806 | N/A | N/A | secretion of glucuronoxylomannan: decreased | secretion of glucuronoxylomannan: decreased | ||||||||||||||||||||
53 | CNAG_00193 | 20673806 | N/A | N/A | utilization of alanine as nitrogen source: decreased | utilization of alanine as nitrogen source: decreased | ||||||||||||||||||||
54 | CNAG_00193 | 20673806 | N/A | N/A | utilization of alanine nitrogen source: absent | utilization of alanine nitrogen source: absent | ||||||||||||||||||||
55 | CNAG_00193 | 20673806 | N/A | N/A | utilization of amino acid as nitrogen source: decreased | utilization of amino acid as nitrogen source: decreased | ||||||||||||||||||||
56 | CNAG_00193 | 20673806 | N/A | N/A | utilization of ammonium as nitrogen source: decreased | utilization of ammonium as nitrogen source: decreased | ||||||||||||||||||||
57 | CNAG_00193 | 21441208 | N/A | N/A | utilization of ammonium as nitrogen source: decreased | utilization of ammonium as nitrogen source: decreased | ||||||||||||||||||||
58 | CNAG_00193 | 20673806 | N/A | N/A | utilization of amonium nitrogen source: absent | utilization of amonium nitrogen source: absent | ||||||||||||||||||||
59 | CNAG_00193 | 20673806 | N/A | N/A | utilization of arginine as nitrogen source: decreased | utilization of arginine as nitrogen source: decreased | ||||||||||||||||||||
60 | CNAG_00193 | 20673806 | N/A | N/A | utilization of arginine nitrogen source:decreased | utilization of arginine nitrogen source:decreased | ||||||||||||||||||||
61 | CNAG_00193 | 20673806 | N/A | N/A | utilization of asparagine as nitrogen source: decreased | utilization of asparagine as nitrogen source: decreased | ||||||||||||||||||||
62 | CNAG_00193 | 20673806 | N/A | N/A | utilization of asparagine nitrogen source: absent | utilization of asparagine nitrogen source: absent | ||||||||||||||||||||
63 | CNAG_00193 | 20673806 | N/A | N/A | utilization of aspartic acid nitrogen source: absent | utilization of aspartic acid nitrogen source: absent | ||||||||||||||||||||
64 | CNAG_00193 | 20673806 | N/A | N/A | utilization of aspartic acid as nitrogen source: decreased | utilization of aspartic acid as nitrogen source: decreased | ||||||||||||||||||||
65 | CNAG_00193 | 21441208 | N/A | N/A | utilization of creatinine as nitrogen source: decreased | utilization of creatinine as nitrogen source: decreased | ||||||||||||||||||||
66 | CNAG_00193 | 20673806 | N/A | N/A | utilization of cysteine as nitrogen source: decreased | utilization of cysteine as nitrogen source: decreased | ||||||||||||||||||||
67 | CNAG_00193 | 20673806 | N/A | N/A | utilization of cysteine nitrogen source: absent | utilization of cysteine nitrogen source: absent | ||||||||||||||||||||
68 | CNAG_00193 | 20673806 | N/A | N/A | utilization of glutamic acid as nitrogen source: decreased | utilization of glutamic acid as nitrogen source: decreased | ||||||||||||||||||||
69 | CNAG_00193 | 20673806 | N/A | N/A | utilization of glutamic acid nitrogen source: absent | utilization of glutamic acid nitrogen source: absent | ||||||||||||||||||||
70 | CNAG_00193 | 20673806 | N/A | N/A | utilization of glutamine as nitrogen source: decreased | utilization of glutamine as nitrogen source: decreased | ||||||||||||||||||||
71 | CNAG_00193 | 20673806 | N/A | N/A | utilization of glutamine nitrogen source: absent | utilization of glutamine nitrogen source: absent | ||||||||||||||||||||
72 | CNAG_00193 | 20673806 | N/A | N/A | utilization of glycine as nitrogen source: decreased | utilization of glycine as nitrogen source: decreased | ||||||||||||||||||||
73 | CNAG_00193 | 20673806 | N/A | N/A | utilization of glycine nitrogen source: absent | utilization of glycine nitrogen source: absent | ||||||||||||||||||||
74 | CNAG_00193 | 20673806 | N/A | N/A | utilization of histidine as nitrogen source: decreased | utilization of histidine as nitrogen source: decreased | ||||||||||||||||||||
75 | CNAG_00193 | 20673806 | N/A | N/A | utilization of histidine nitrogen source: absent | utilization of histidine nitrogen source: absent | ||||||||||||||||||||
76 | CNAG_00193 | 20673806 | N/A | N/A | utilization of isoleucine as nitrogen source: decreased | utilization of isoleucine as nitrogen source: decreased | ||||||||||||||||||||
77 | CNAG_00193 | 20673806 | N/A | N/A | utilization of isoleucine nitrogen source: absent | utilization of isoleucine nitrogen source: absent | ||||||||||||||||||||
78 | CNAG_00193 | 20673806 | N/A | N/A | utilization of leucine as nitrogen source: decreased | utilization of leucine as nitrogen source: decreased | ||||||||||||||||||||
79 | CNAG_00193 | 20673806 | N/A | N/A | utilization of leucine nitrogen source: absent | utilization of leucine nitrogen source: absent | ||||||||||||||||||||
80 | CNAG_00193 | 20673806 | N/A | N/A | utilization of lysine as nitrogen source: decreased | utilization of lysine as nitrogen source: decreased | ||||||||||||||||||||
81 | CNAG_00193 | 20673806 | N/A | N/A | utilization of lysine nitrogen source: decreased | utilization of lysine nitrogen source: decreased | ||||||||||||||||||||
82 | CNAG_00193 | 20673806 | N/A | N/A | utilization of methionine nitrogen source: absent | utilization of methionine nitrogen source: absent | ||||||||||||||||||||
83 | CNAG_00193 | 20673806 | N/A | N/A | utilization of phenylaanine nitrogen source: absent | utilization of phenylaanine nitrogen source: absent | ||||||||||||||||||||
84 | CNAG_00193 | 20673806 | N/A | N/A | utilization of phenylalanine as nitrogen source: decreased | utilization of phenylalanine as nitrogen source: decreased | ||||||||||||||||||||
85 | CNAG_00193 | 20673806 | N/A | N/A | utilization of proline as nitrogen source: decreased | utilization of proline as nitrogen source: decreased | ||||||||||||||||||||
86 | CNAG_00193 | 20673806 | N/A | N/A | utilization of proline nitrogen source: decreased | utilization of proline nitrogen source: decreased | ||||||||||||||||||||
87 | CNAG_00193 | 20673806 | N/A | N/A | utilization of serine as nitrogen source: decreased | utilization of serine as nitrogen source: decreased | ||||||||||||||||||||
88 | CNAG_00193 | 20673806 | N/A | N/A | utilization of serine nitrogen source: absent | utilization of serine nitrogen source: absent | ||||||||||||||||||||
89 | CNAG_00193 | 20673806 | N/A | N/A | utilization of threonine nitrogen source: absent | utilization of threonine nitrogen source: absent | ||||||||||||||||||||
90 | CNAG_00193 | 20673806 | N/A | N/A | utilization of threonine nitrogen source: decreased | utilization of threonine nitrogen source: decreased | ||||||||||||||||||||
91 | CNAG_00193 | 20673806 | N/A | N/A | utilization of tryptophan as nitrogen source: decreased | utilization of tryptophan as nitrogen source: decreased | ||||||||||||||||||||
92 | CNAG_00193 | 20673806 | N/A | N/A | utilization of tryptophan nitrogen source: absent | utilization of tryptophan nitrogen source: absent | ||||||||||||||||||||
93 | CNAG_00193 | 20673806 | N/A | N/A | utilization of tyrosine as nitrogen source: decreased | utilization of tyrosine as nitrogen source: decreased | ||||||||||||||||||||
94 | CNAG_00193 | 20673806 | N/A | N/A | utilization of tyrosine nitrogen source: absent | utilization of tyrosine nitrogen source: absent | ||||||||||||||||||||
95 | CNAG_00193 | 20673806 | N/A | N/A | utilization of urea as nitrogen source: decreased | utilization of urea as nitrogen source: decreased | ||||||||||||||||||||
96 | CNAG_00193 | 21441208 | N/A | N/A | utilization of urea as nitrogen source: decreased | utilization of urea as nitrogen source: decreased | ||||||||||||||||||||
97 | CNAG_00193 | 20673806 | N/A | N/A | utilization of urea nitrogen source: absent | utilization of urea nitrogen source: absent | ||||||||||||||||||||
98 | CNAG_00193 | 21441208 | N/A | N/A | utilization of uric acid as nitrogen source: decreased | utilization of uric acid as nitrogen source: decreased | ||||||||||||||||||||
99 | CNAG_00193 | 20673806 | N/A | N/A | utilization of valine as nitrogen source: decreased | utilization of valine as nitrogen source: decreased | ||||||||||||||||||||
100 | CNAG_00193 | 20673806 | N/A | N/A | utilization of valine nitrogen source: absent | utilization of valine nitrogen source: absent |